Atrial fibrillation (AF) is a common arrhythmia and a major risk factor for ischemic stroke, especially in the elderly. Patients with nonvalvular AF have a 5-fold excess risk of stroke. However, population-based data are scarce in patients who have experienced a first-ever ischemic stroke in the presence of AF regarding long-term risk of stroke recurrence and casefatality rate.
Introduction
Globally stroke is a major health problem. It is the third commonest cause of mortality 1 and fourth leading cause of disease burden 2 . It is of two main types -ischemic and hemorrhagic 3 . Among the cardiac risk factors for ischemic stroke the incidence of thromboembolism in patients with atrial fibrillation is 4% to 7.5% per year. The prevalence of atrial fibrillation increases with advancing age and is 0.5% for patients aged 50 to 59 years and 8.8% for those aged 80 to 89 years. Chronic non-valvular atrial fibrillation (NVAF), a condition that is associated with an overall risk for stroke of approximately five to six fold, and a mortality rate approximately twice that of age and sex matched individuals without atrial fibrillation 4 .By 2050, it is anticipated that 80% of stroke events will occur in people living in developing regions of the world 5, 6 . Atrial fibrillation, the most common sustained cardiac arrhythmia in the general population, affects about 1% of adults, is the most common cause for cardioembolic stroke and is a risk factor for future cerebrovascular diseases. Patients with rheumatic atrial fibrillation have a 17-fold increase in stroke incidence 4 . Some studies showed that stroke patients with AF have been shown to have a poorer neurological outcome than stroke patients without AF. But we have very limited studies done in this field in our country perspective.
Objective
To find out the prevalence of atrial fibrillation and its effect upon the outcome of ischemic stroke patient presented in Rajshahi Medical College Hospital.
Material and Methods
This study was performed in Neuromedicine department of Rajshahi Medical College Hospital from January 2013 to December 2014. It was a descriptive type cross sectional study. The patients who fulfilled both the inclusion and exclusion criteria were included in our study. ECG was done to find out presence of atrial fibrillation. So two group was found -one with atrial fibrillation and other without atrial fibrillation. Initially they were assessed by Modified Rankin score. Then they were followed up after one month, three months and six-month interval. Outcome was recorded with the help of modified rankin score. Comparison was done between the atrial fibrillation and non-atrial fibrillation group in terms of recurrence, mortality and clinical improvement. Data was collected by face to face interview, physical examination and investigations in a data collection sheet. Some patients were followed up on outdoor service. Data were analyzed on SPSS 16.0. Mean and standard deviation were computed with the students t-test, where non-parametric variables were analyzed by Chi-square method and unless otherwise stated, p <0.05 was taken as significant.
Inclusion criteria:
Clinical and neuroimaging features of ischemic stroke.
Exclusion criteria:
Recurrence of stroke
Result
Total 125 patients who met the inclusion and exclusion criteria were included in the study. Among them atrial fibrillation was present in 22 patients by ECG evaluation on admission. In the atrial fibrillation group 12 (54.5%) were men and 10 (45.5%) were women. On the other hand in the non-atrial fibrillation group 63 (61.2%) were men and 40 (38.8%) were women. So in our study there was male predominance in atrial fibrillation group. Table IV shows that after one month 10 patients improved, 12 ware static and no patient deteriorated clinically in atrial fibrillation group. On the other hand, 65 patients improved, 37 patients remained static and 1 patient deteriorated in non-atrial fibrillation group. P value (t=1.559, df = 123, p>0.05). It is statistically insignificant. After three months 16 patients improved, 4 ware static and 2 patient deteriorated clinically in atrial fibrillation group. On the other hand 97 patients improved, 3 patients remained static and 3 patients deteriorated in non-atrial fibrillation group. P value (t=3.039, df = 123, p<0.01). It is statistically significant. After six months 18 patients improved, no patient was static and 4 patients deteriorated clinically in atrial fibrillation group. On the other hand 96 patients improved, 2 patients remained static and 5 patients deteriorated in non-atrial fibrillation group. P value (t=2.847, df = 123, p<0.01). It is statistically significant. 
Discussion
The present study was carried out in Rajshahi Medical College Hospital, Rajshahi. The role of AF was investigated in patients who had a firstever ischemic stroke documented with brain neuroimaging and electrocardiogram. A total number of 125 patients were included in the study
In our study one-month mortality was not significant in atrial fibrillation group when compared with non-atrial fibrillation group (4.5% versus 1.0%, p>0.05) but after 3 months follow up there was significant case fatality in patients with atrial fibrillation (13.6% versus 2.9%, p<0.05) and after 6 months follow up it was also significant (22.7% versus 4.9%, p<0.05). In a previous study 7 it was found that death was significant in patients with atrial fibrillation after 28 days of hospital admission when compared with non-atrial fibrillation (mortality 11.3% versus 3.4%, p<0.0001). Similar high mortality was noticed by Carini et al. (2005) 
Conclusion
Ischemic stroke patients with atrial fibrillation had significant mortality within the study period compared to those without atrial fibrillation. Clinical improvement was not significant within one month but significant deterioration was noted in atrial fibrillation group after six months. Recurrence was more in ischemic stroke patients with atrial fibrillation especially at one month follow up. So, in conclusion patients who had an ischemic stroke with accompanying atrial fibrillation had higher mortality, graver stroke severity, more recurrences and poorer functional status than those without atrial fibrillation.
